Pulsed field ablation for atrial fibrillation
Part of Heart & circulation clinical trials.
This study tests a new way to treat atrial fibrillation (AFib) using pulsed electrical energy to target the heart tissue that causes the irregular rhythm. It aims to see if this method is safe and effective for people having their first such treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must have atrial fibrillation (an irregular heartbeat) and be eligible for a first-time pulmonary vein isolation procedure according to standard guidelines.
- You must not have had any prior ablation in the left atrium (the upper left chamber of your heart).
- You must not have other left atrial rhythm problems, such as atrial flutter.
- You must be able to undergo a cardiac MRI, meaning you have no metal implants or devices, no severe kidney disease, and no allergy to contrast dye.
- You must not have severe leakage of the mitral valve (a heart valve on the left side).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a special catheter that uses pulsed field energy to ablate (destroy) the tiny areas in the heart causing irregular heartbeats. It is designed for people with paroxysmal atrial fibrillation (episodes that come and go) that hasn't been controlled by medication.
This trial studies a new procedure called pulsed field ablation to treat brief episodes of atrial fibrillation (AFib). The goal is to see if it can help reset the heart's natural electrical system and reduce symptoms.
This study tests a new way to do a heart procedure (catheter ablation) for people with ongoing atrial fibrillation (an irregular heartbeat). It uses pulsed-field energy to create a block in the heart that stops abnormal electrical signals. The goal is to improve the procedure's success and reduce risks.
This trial tests a new way to treat non-paroxysmal atrial fibrillation (AF) using a focused type of ablation (pulsed-field energy) on specific areas of the heart. It aims to see if targeting the left atrial wall and mitral isthmus can improve outcomes for people who have not had this procedure before.
This trial tests a newer ablation technique called pulsed field ablation to treat atrial fibrillation, a heart rhythm disorder. The goal is to see if this method works well and is safe for patients who need treatment.
This study tests a newer, gentler way to fix irregular heartbeats in people with paroxysmal AF. The treatment uses special energy (pulsed fields) guided by 3D imaging to target the heart tissue causing the problem, and the goal is to restore a normal rhythm with fewer risks.
Hear when a new Atrial Fibrillation (AF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.